209 related articles for article (PubMed ID: 36553598)
1. The Diverse Role of CUB and Sushi Multiple Domains 1 (CSMD1) in Human Diseases.
Ermis Akyuz E; Bell SM
Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553598
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway.
Chen XL; Hong LL; Wang KL; Liu X; Wang JL; Lei L; Xu ZY; Cheng XD; Ling ZQ
Int J Biol Sci; 2019; 15(10):2075-2086. PubMed ID: 31592231
[No Abstract] [Full Text] [Related]
3. Clinical Significance of CUB and Sushi Multiple Domains 1 Inactivation in Head and Neck Squamous Cell Carcinoma.
Jung AR; Eun YG; Lee YC; Noh JK; Kwon KH
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545040
[TBL] [Abstract][Full Text] [Related]
4. Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.
Ma C; Quesnelle KM; Sparano A; Rao S; Park MS; Cohen MA; Wang Y; Samanta M; Kumar MS; Aziz MU; Naylor TL; Weber BL; Fakharzadeh SS; Weinstein GS; Vachani A; Feldman MD; Brose MS
Cancer Biol Ther; 2009 May; 8(10):907-16. PubMed ID: 19276661
[TBL] [Abstract][Full Text] [Related]
5. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
[TBL] [Abstract][Full Text] [Related]
6. CSMD1 suppresses cancer progression by inhibiting proliferation, epithelial-mesenchymal transition, chemotherapy-resistance and inducing immunosuppression in esophageal squamous cell carcinoma.
Wang X; Chen X; Liu Y; Huang S; Ding J; Wang B; Dong P; Sun Z; Chen L
Exp Cell Res; 2022 Aug; 417(2):113220. PubMed ID: 35623420
[TBL] [Abstract][Full Text] [Related]
7. Altered CSMD1 Expression Alters Cocaine-Conditioned Place Preference: Mutual Support for a Complex Locus from Human and Mouse Models.
Drgonova J; Walther D; Singhal S; Johnson K; Kessler B; Troncoso J; Uhl GR
PLoS One; 2015; 10(7):e0120908. PubMed ID: 26171607
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of the CSMD1 gene in the peripheral blood of schizophrenia patients.
Liu Y; Fu X; Tang Z; Li C; Xu Y; Zhang F; Zhou D; Zhu C
BMC Psychiatry; 2019 Apr; 19(1):113. PubMed ID: 30987620
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-642b-3p functions as an oncomiR in gastric cancer by down-regulating the CUB and sushi multiple domains protein 1/smad axis.
Liu H; Chen Y; Zhou L; Jiang X; Zhou X
Bioengineered; 2022 Apr; 13(4):9613-9627. PubMed ID: 35412956
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations, allele loss, and DNA methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) gene reveals association with early age of diagnosis in colorectal cancer patients.
Shull AY; Clendenning ML; Ghoshal-Gupta S; Farrell CL; Vangapandu HV; Dudas L; Wilkerson BJ; Buckhaults PJ
PLoS One; 2013; 8(3):e58731. PubMed ID: 23505554
[TBL] [Abstract][Full Text] [Related]
11. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
Escudero-Esparza A; Kalchishkova N; Kurbasic E; Jiang WG; Blom AM
FASEB J; 2013 Dec; 27(12):5083-93. PubMed ID: 23964079
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychological deficits in mice depleted of the schizophrenia susceptibility gene CSMD1.
Steen VM; Nepal C; Ersland KM; Holdhus R; Nævdal M; Ratvik SM; Skrede S; Håvik B
PLoS One; 2013; 8(11):e79501. PubMed ID: 24244513
[TBL] [Abstract][Full Text] [Related]
13. Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
Gialeli C; Tuysuz EC; Staaf J; Guleed S; Paciorek V; Mörgelin M; Papadakos KS; Blom AM
J Exp Clin Cancer Res; 2021 Aug; 40(1):258. PubMed ID: 34404439
[TBL] [Abstract][Full Text] [Related]
14. Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.
Escudero-Esparza A; Bartoschek M; Gialeli C; Okroj M; Owen S; Jirström K; Orimo A; Jiang WG; Pietras K; Blom AM
Oncotarget; 2016 Nov; 7(47):76920-76933. PubMed ID: 27764775
[TBL] [Abstract][Full Text] [Related]
15. The Role of Csmd1 during Mammary Gland Development.
Burgess SJ; Gibbs H; Toomes C; Coletta PL; Bell SM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33530646
[TBL] [Abstract][Full Text] [Related]
16. Identification of two new members of the CSMD gene family.
Lau WL; Scholnick SB
Genomics; 2003 Sep; 82(3):412-5. PubMed ID: 12906867
[TBL] [Abstract][Full Text] [Related]
17.
Huang T; Liang Y; Zhang H; Chen X; Wei H; Sun W; Wang Y
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828321
[TBL] [Abstract][Full Text] [Related]
18. miR-10b exerts oncogenic activity in human hepatocellular carcinoma cells by targeting expression of CUB and sushi multiple domains 1 (CSMD1).
Zhu Q; Gong L; Wang J; Tu Q; Yao L; Zhang JR; Han XJ; Zhu SJ; Wang SM; Li YH; Zhang W
BMC Cancer; 2016 Oct; 16(1):806. PubMed ID: 27756250
[TBL] [Abstract][Full Text] [Related]
19. CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues.
Kraus DM; Elliott GS; Chute H; Horan T; Pfenninger KH; Sanford SD; Foster S; Scully S; Welcher AA; Holers VM
J Immunol; 2006 Apr; 176(7):4419-30. PubMed ID: 16547280
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability.
Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC
Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]